Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Britannia Life Sciences Inc Com C.RLSC

RISE Life Science Corp is engaged in developing and evolving medical and adult hemp-based formulations to create general use of health and well-being products for the emerging consumer category. It derives key revenue from the United States.


CSE:RLSC - Post by User

Post by GianniM1on Jan 18, 2016 8:58pm
213 Views
Post# 24470588

Translated Italian article with small mention of Miraculins.

Translated Italian article with small mention of Miraculins.


Hopefully their device gains traction and becomes the leading tool in this space...



Diagnosis of diabetes and innovative technologies
Selecting Electronics • January 13, 2016
  

The field of diagnostic of diabetes is experiencing a renaissance, because the high concentration of the market and regulatory changes are forcing companies to build platforms and different devices. Tests developed higher thanks to the discovery of new markers, such as microalbuminuria or glycated albumin, supplant glucose tests expanding market reach. New analysis from Frost & Sullivan finds that the market earned revenues of 9.04 billion dollars in 2014 and estimates this will rise 10.90000000000 dollars in 2020. "In the next decade, the non-invasive methods such as biosensors , infrared patches and patch essentially replace the disposable test blood glucose monitoring, "said Aish Vivekanandan, an analyst at Frost & Sullivan. "The pioneering non-invasive technologies such as contact lenses of Google that analyze the tears and point-of-care testing noninvasive Miraculins transform diagnostic of diabetes."

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse